Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia

NCT04001023 is registered in ClinicalTrials.gov with Turku University Hospital as lead sponsor.

NCT NCT04001023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04001023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia
Lead sponsor
Turku University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 9, 2017
Completion date
December 31, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epithelial ovarian cancer, fallopian tube cancer, hypoxia, peritoneal carcinoma